SCHEMBL19398043

SCHEMBL19398043

CC(C)OP(=O)(OC(C)C)C(=Cc1cccc2ccccc12)P(=O)(OC(C)C)OC(C)C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.48
HMGCR P04035 1/20 0.42
NR1I2 O75469 1/20 0.42
ALDH1A1 P00352 3/20 0.41
F2 P00734 1/20 0.41
LMNA P02545 1/20 0.41
SMPD2 O60906 1/20 0.39
MTNR1A P48039 1/20 0.39
MTNR1B P49286 1/20 0.39
GRIN2D O15399 2/20 0.38
GRIN3B O60391 2/20 0.38
GRIN1 Q05586 2/20 0.38
GRIN2A Q12879 2/20 0.38
GRIN2B Q13224 2/20 0.38
GRIN2C Q14957 2/20 0.38
GRIN3A Q8TCU5 2/20 0.38
HDAC8 Q9BY41 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
MAPT P10636 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19279396 0.85 KDM4E (0.45) KDM4EALDH1A1F2LMNASMPD2
SCHEMBL9358736 0.81 HMGCR (0.44) KDM4EHMGCRNR1I2ALDH1A1L3MBTL1
SCHEMBL19279399 0.79 NR1I2 (0.66) KDM4EHMGCRNR1I2ALDH1A1LMNA
SCHEMBL11046152 0.73 KDM4E (0.47) KDM4ENR1I2ALDH1A1F2LMNA
SCHEMBL10888977 0.73 KDM4E (0.47) KDM4ENR1I2ALDH1A1F2LMNA
SCHEMBL11515536 0.73 KDM4E (0.50) KDM4EALDH1A1HDAC8L3MBTL1MAPT
SCHEMBL19398053 0.72 NR1I2 (0.56) KDM4EHMGCRNR1I2ALDH1A1LMNA
SCHEMBL20852695 0.70 NR1I2 (0.53) KDM4ENR1I2ALDH1A1LMNAMTNR1A
SCHEMBL10662062 0.69 KDM4E (0.52) KDM4EALDH1A1F2LMNASMPD2
SCHEMBL20182010 0.68 KDM4E (0.55) KDM4EHMGCRALDH1A1LMNAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10377781-B2 Alkylidene phosphonate esters as p-glycoprotein inducers COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2019-08-13 US disclosed
US-20170275314-A1 ALKYLIDENE PHOSPHONATE ESTERS AS P-GLYCOPROTEIN INDUCERS COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2017-09-28 US disclosed
US-20170275314-A1 ALKYLIDENE PHOSPHONATE ESTERS AS P-GLYCOPROTEIN INDUCERS COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2017-09-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10377781-B2 Alkylidene phosphonate esters as p-glycoprotein inducers ABCB1, ABCC2, ABCC4 KDM4E 3375/4885HMGCR 307/4885NR1I2 87/4885
US-20170275314-A1 ALKYLIDENE PHOSPHONATE ESTERS AS P-GLYCOPROTEIN INDUCERS ABCB1, ABCC2, ABCC4 KDM4E 3375/4885HMGCR 307/4885NR1I2 87/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.